Total global pharmaceutical R&D spending 2010-2024
Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
In 2018, research and development spending in the pharmaceutical industry totaled 1790 billion U.S. dollars globally. For comparison, R&D expenditures totaled 129 billion dollars in 2010. Pharmaceutical R&D includes all steps from the initial research of disease processes, the compound testing over pre-clinical, and all clinical trial stages. At a certain point in the process -mostly during the pre-clinical phase – a governmental authority is involved to overview, regulate, and ultimately approve the drug. In the United States, the Food and Drug Administration headquartered in White Oaks, Maryland, is the principal agency associated with processes.
The pressure to innovate
In comparison to other industries, pharmaceutical companies are more driven by the imperative to manufacture innovative products, and thus to spend significant amounts on research and development. This is largely due to the time-limited patent protection of drugs and the following threat of sales erosion through generic and biosimilar competition. Two major effects of patent expirations for the pharma industry are a specific high R&D intensity and a growing focus on specialty drugs to diversify their product portfolio.
The latest trends
For the last several years, major developments in pharmaceutical research and development have begun to change the R&D landscape. A growing number of drug manufacturers are outsourcing large parts of R&D, mostly to clinical research organizations (also: contract research organizations), with the main aim to reduce costs. Another important development is the use of big data in clinical research. Thus, a predictive modeling is possible which uses clinical and molecular data to develop safer and more efficient drugs. Particularly, real-time or real-world evidence (RWE) is becoming a greater interest. This makes cooperation with technology companies necessary and includes data gathered from various sources, even that of social media.
Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
Source
More information
Other statistics on the topic
Global Pharmaceutical Industry
Statistics on "Global pharmaceutical industry"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Global pharmaceutical industry by gross value added 2006-2014
- Teaching hospitals with highest payments from pharma companies in U.S. 2013-2016
- Global pharmaceutical industry labor productivity per employee by region 2012
- Most paid doctors by pharma and medtech companies in U.S. 2013-2016
- Top US teaching hospitals by highest number of company payments 2013-2016
- Global pharmaceutical industry by gross value added by region 2014
- Share of global pharmaceutical industry by gross value added by region 2014
- Pharmaceutical industry by global share of gross value added 2006-2012
- States with highest payments by companies to doctors in U.S. 2013-2016
- Global pharmaceutical industry by growth rate of salaries per employee 2006-2012
- Global pharmaceutical industry by wages and salaries per employee 2006-2014
- Global pharmaceutical industry by growth rate in wages and salaries 2006-2014
- Global pharmaceutical industry by production value growth rate 2006-2014
- Global pharmaceutical industry by employees by region 2014
- Global pharmaceutical industry by production value 2006-2014
- Antidepressants pharmaceutical consumption in Czechia 2005-2016
- Terumo net sales FY 2012-2017
- U.S. pharmaceutical industry - domestic and abroad revenue 1975-2017
- Value of exports of pharmaceutical products from Spain to the UK 2012-2016
- Drug production value share of central nervous system agents Japan 2016, by category
Statistics on "Global pharmaceutical industry"
Related topics
About Statista
